Long-Haul COVID and Neurologic Symptoms: What Neurologists Know So Far
Several studies provide evidence for neurologic and neuropsychiatric morbidity during and after COVID-19 infection—a phenomenon known as “long-haul COVID.”1 People…
Several studies provide evidence for neurologic and neuropsychiatric morbidity during and after COVID-19 infection—a phenomenon known as “long-haul COVID.”1 People…
A patient’s gut microbiome may be linked to the risk of developing long-haul COVID-19 after initial infection with SARS-CoV-2, according…
Individuals who have asymptomatic COVID-19 may develop post-COVID conditions. These conditions can present as different types and combinations of health…
As 2021 ended and 2022 began, the COVID-19 pandemic kicked into high gear yet again with the advent of the…
More than 2 years ago, the alarm and first warnings of a global pandemic sounded. Now with over 830,000 deaths…
A single dose of Ad5-nCoV, an adenovirus type 5 (Ad5) vectored vaccine expressing the SARS-CoV-2 spike protein, was found to…
While sleep-disordered breathing (SDB) and sleep-related hypoxia do not increase the risk of SARS-CoV-2 infection, sleep-related hypoxia may be a…
A 65-year-old woman presents to the emergency department with complaints of shortness of breath, sore throat, fever, chills, productive cough,…
During the height of the coronavirus disease (COVID-19) pandemic between 2019 and 2020, there was a substantial decrease in the…
Patients with cancer who are hospitalized for COVID-19 have an increased risk of death but are less likely to receive…